Back to search
FDAFDA · Food and drugs·Recall number D-0483-2026

EPINEPHRINE Injection, USP, 1 mg/10mL (0.1 mg/mL), Rx only, INTERNATIONAL MEDICATION SYSTEMS, LIMITED, So. EL Monte, CA 91733, An Amphastar Pharmaceutical Company, NDC 76329-3318-1

Published April 22, 2026 · Recall initiated: April 1, 2026

Summary

FDA records drug Class II recall D-0483-2026, published April 22, 2026 and initiated April 1, 2026. Recalling firm: International Medication Systems Ltd.; Status: Ongoing; Reported quantity: 81,520 units; Lot: Lot Number: EA038A5, Expiration Date: 08/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility

What to do

Voluntary: Firm initiated · Letter

Get an email if EPINEPHRINE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
EPINEPHRINE
Manufacturer
International Medication Systems Ltd.
Distributor
U.S. Nationwide
Lot
Lot Number: EA038A5, Expiration Date: 08/2026.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was EPINEPHRINE Injection, USP, 1 mg/10mL (0.1 mg/mL), Rx only, INTERNATIONAL MEDICATION SYSTEMS, LIMITED, So. EL Monte, CA 91733, An Amphastar Pharmaceutical Company, NDC 76329-3318-1 recalled?

Yes. FDA published recall D-0483-2026 on April 22, 2026. Reported hazard: Lack of Assurance of Sterility

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: EPINEPHRINE.